Berg SIT, Cutler MJ, Blay J. Changes in matrix metalloproteinase expression in SN-38 resistant colorectal cancer cells. Clinical Cancer Research. 2015;21:A04.

Cutler MJ, Lowthers EL, Richard CL, Hajducek DM, Spagnuolo PA, Blay J. Chemotherapeutic agents attenuate CXCL12-mediated migration of colon cancer cells by selecting for CXCR4-negative cells and increasing peptidase CD26. BMC Cancer. 2015;15:882.

​Lefort EC, Blay J. Apigenin and its impact on gastrointestinal cancers. Molecular Nutrition and Food Research. 2013;57(1):126-144.

Lefort ÉC, Blay J. The dietary flavonoid apigenin enhances the activities of the anti-metastatic protein CD26 on human colon carcinoma cells. Clinical and Experimental Metastasis. 2011;28(4):337-349.

Yadav PN, Beveridge RE, Blay J, et al. Platinum-oxazoline complexes as anti-cancer agents: Syntheses, characterisation and initial biological studies. MedChemComm. 2011;2(4):274-277.

Roy JW, Cowley EA, Blay J, Linsdell P. The intermediate conductance ca 2+-activated K + channel inhibitor TRAM-34 stimulates proliferation of breast cancer cells via activation of oestrogen receptors. Br J Pharmacol. 2010;159(3):650-658.

Blay J, Price RB. Cellular inhibition produced by dental curing lights is a heating artifact. Journal of Biomedical Materials Research - Part B Applied Biomaterials. 2010;93(2):367-374.

Hoskin DW, Mader JS, Furlong SJ, Conrad DM, Blay J. Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (review). Int J Oncol. 2008;32(3):527-535.

Richard CL, Blay J. CXCR4 in cancer and its regulation by PPAR gamma. PPAR Research 2008.

Roy J, Vantol B, Cowley EA, Blay J, Linsdell P. Pharmacological separation of hEAG and hERG K+ channel function in the human mammary carcinoma cell line MCF-7. Oncol Rep 2008;19(6):1511-1516.

Borissow CN, Graham CL, Syvitski RT, Reid TR, Blay J, Jakeman DL. Stereochemical integrity of oxazolone ring-containing jadomycins. ChemBioChem. 2007;8(10):1198-1203.

Baguma-Nibasheka M, Barclay C, Li AW, et al. Selective cyclooxygenase-2  inhibition suppresses basic fibroblast growth factor expression in human  esophageal adenocarcinoma. Mol Carcinog. 2007;46(12):971-980.

Richard CL, Blay J. Thiazolidinedione drugs down-regulate  CXCR4  expression on human colorectal cancer cells in a peroxisome proliferator  activated receptor γ-dependent manner. Int J Oncol. 2007;30(5):1215- 1222.

Richard CL, Lowthers EL, Blay J. 15-deoxy-Δ12,14-prostaglandin J2  down-regulates CXCR4 on carcinoma cells through PPARγ- and  NFκB-mediated pathways. Exp Cell Res. 2007;313(16):3446-3458.